Abstract
Myocardial infarction (MI) is a common cause of mortality worldwide. Isorhapontigenin is a derivative of stilbene with chemical structure similar to resveratrol. The omega-3 fatty acids (FA) have beneficial effects on neurodegenerative, inflammatory, and cardiovascular diseases. The aim of this study was to investigate the effects of pretreatment with isorhapontigenin and omega-3 FA on rat model of isoproterenol-induced MI. Fifty-six rats were divided into seven groups: normal, normal + isorhapontigenin, normal + omega-3 FA, MI, MI + isorhapontigenin, MI + omega-3 FA, and MI + isorhapontigenin + omega-3 FA. Serum levels of cardiac marker enzymes [lactate dehydrogenase (LDH) and creatine kinase-MB (CK-MB)], cardiac troponin I (cTnI), inflammatory markers [tumor necrosis factor-alpha (TNF-α) and interleukin-6], and lipid profile [triglycerides, total cholesterol (T.Ch), high and low density lipoproteins (HDL, LDL), and phospholipids] as well as cardiac levels of malondialdehyde and anti-oxidants [reduced glutathione (GSH), superoxide dismutase (SOD), and catalase)] were measured in all rats. ECG and histopathological examination were performed. Isoproterenol caused a significant elevation of ST segment, decreased R wave amplitude, HDL, and anti-oxidants, and increased LDH, CK-MB, cTnI, TNF-α, interleukin-6, malondialdehyde, triglycerides, T.Ch, LDL, and phospholipids. Omega-3 FA or isorhapontigenin significantly decreased the ST segment elevation, LDH, CK-MB, cTnI, TNF-α, interleukin-6, malondialdehyde, and phospholipids and increased R wave amplitude and anti-oxidants. The effects of combined omega-3 FA and isorhapontigenin were more significant than either of them alone. Therefore, we conclude that omega-3 FA and isorhapontigenin have a cardioprotective effect on rats with isoproterenol-induced MI through their anti-oxidant and anti-inflammatory actions.
Similar content being viewed by others
References
Adkins Y, Kelley DS (2010) Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 21:781–792
Baumann KH, Hessel F, Larass I et al (1999) Dietary -3, -6 and -9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. Arterioscler Thromb Vasc Biol 19:59–66
Bosch J, Gerstein HC, Dagenais GR et al (2012) N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 367(4):309–318
Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T, Zotos PC, Haboubi NA, Elwood PC (2003) Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 57:193–200
Chen YR, Yi FF, Li XY, Wang CY, Chen L, Yang XC, Su PX, Cai JR (2008) Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction. Cardiovasc Drugs Ther 22:479–485
Connor WE (2000) Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 71:171S–175S
Cosar M, Songur A, Sahin O, Uz E, Yilmaz R, Yagmurca M et al (2008) The neuroprotective effect of fish n-3 fatty acids in the hippocampus of diabetic rats. Nutr Neurosci 11:161–166
El-Gendy AA, Abbas AM (2014) Effect of omega-3 fatty acids on haemostatic functions in urocortin-treated obese rats. J Physiol Biochem 70:809–820
Eleawa SM, Alkhateeb M, Ghosh S, Al-Hashem F, Shatoor AS, Alhejaily A, Khalil MA (2015) Coenzyme Q10 protects against acute consequences of experimental myocardial infarction in rats. Int J Physiol Pathophysiol Pharmacol 7(1):1–13
Fernández-Marín MI, Guerrero RF, García-Parrilla MC, Puertas B, Richard T, Rodriguez-Werner MA, Winterhalter P, Monti JP, Cantos-Villar E (2012) Isorhapontigenin: a novel bioactive stilbene from wine grapes. Food Chem 135:1353–1359
Fox KAA, Steg PG, Eagle KA et al (2007) Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA 297(17):1892–1900
Hirafuji M, Machida T, Hamaue N, Minami M (2003) Cardiovascular protective effects of n-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid. J Pharmacol Sci 92:308–316
Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ et al (2006) Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. Br Med J 332:752–760
Kang JX, Xiao YF, Leaf A (1995) Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A 92:3997–4001
Kareem MA, Krushna GS, Hussain SA, Devi KL (2009) Effect of aqueous extract of nutmeg on hyperglycaemia, hyperlipidaemia and cardiac histology associated with isoproterenol-induced myocardial infarction in rats. Trop J Pharm Res 8(4):337
Karthikeyan K, Bai BRS, Devaraj SN (2007) Efficacy of grape seed proanthocyanidins on serum and heart tissue lipids in rats subjected to isoproterenol-induced myocardial injury. Vascul Pharmacol 47:295–301
Kawakami S, Kinoshita Y, Maruki-Uchida H, Yanae K, Sai M, Ito T (2014) Piceatannol and its metabolite, isorhapontigenin, induce SIRT1 expression in THP-1 human monocytic cell line. Nutrients 6:4794–4804
Khalil MI, Tanvir EM, Afroz R, Sulaiman SA, Gan SH (2015) Cardioprotective effects of tualang honey: amelioration of cholesterol and cardiac enzymes levels. BioMed Research International. Volume 2015, Article ID 286051
Kromhout D, Giltay EJ, Geleijnse JM, Alpha Omega Trial Group (2010) n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363:2015–2026
Li H, Wang A, Huang Y et al (2005) Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med 38(2):243–257
Lin JF, Lin SM, Chih CL, Nien MW, Su HH, Hu BR, Huang SS, Tsai SK (2008) Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats. Life Sci 83:313–317
Lobo Filho HG, Ferreira NL, de Sousa RB, de Carvalho ER, Dantas Lobo PL, Lobo Filho JG (2011) Experimental model of myocardial infarction induced by isoproterenol in rats. Rev Bras Cir Cardiovasc 26(3):469–476
London B, Albert C, Anderson ME, Giles WR, Van Wagoner DR, Balk E, Billman GE, Chung M, Lands W, Leaf A, McAnulty J, Martens JR, Costello RB, Lathrop DA (2007) Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research. Circulation 116:e320–e335
Murugesan M, Manju V (2012) Effect of luteolin on lipid peroxidation and antioxidants in acute and chronic periods of isoproterenol induced myocardial infarction in rats. J Acute Med 2:70–76
Nounou HA, Deif MM, Shalaby MA (2012) Effect of flaxseed supplementation and exercise training on lipid profile, oxidative stress and inflammation in rats with myocardial ischemia. Lipids Health Dis 11:129
Osadchii OE, Norton GR, McKechnie R, Deftereos D, Woodiwiss AJ (2007) Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic β-adrenoreceptor activation. Am J Physiol Heart Circ Physiol 292(4):H1898–H1905
Ozen OA, Cosar M, Sahin O, Fidan H, Eser O, Mollaoglu H et al (2008) The protective effect of fish n-3 fatty acids on cerebral ischemia in rat prefrontal cortex. Neurol Sci 29:147–152
Patel V, Upaganlawar A, Zalawadia R, Balaraman R (2010) Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur J Pharmacol 644(1–3):160–168
Pervaiz S, Holme AL (2009) Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 11(11):2851–2897
Priscilla DH, Prince PSM (2009) Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. Chem Biol Interact 179:118–124
Radhiga T, Rajamanickam C, Senthil S, Pugalendi KV (2012) Effect of ursolic acid on cardiac marker enzymes, lipid profile and macroscopic enzyme mapping assay in isoproterenol-induced myocardial ischemic rats. Food Chem Toxicol 50(11):3971–3977
Rallidis LS, Paschos G, Papaioannou ML et al (2004) The effect of diet enriched with α-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients. Atherosclerosis 174:127–132
Ramesh CV, Malarvannan P, Jayakumar R, Jayasundar S, Puvanakrishnan R (1998) Effect of a novel tetrapeptide derivative in a model of isoproterenol induced myocardial necrosis. Mol Cell Biochem 187:173–182
Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events. JAMA 308:1024–1033
Rona G (1985) Catecholamine cardiotoxicity. J Mol Cell Cardiol 17:291–306
Rustan AC, Nossen JO, Christiansen EN, Drevon CA (1988) Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyl-transferase. J Lipid Res 29:1417–1426
Saravanan G, Ponmurugan P, Sathiyavathi M, Vadivukkarasi S, Sengottuvelu S (2013) Cardioprotective activity of Amaranthus viridis Linn: effect on serum marker enzymes, cardiac troponin and antioxidant system in experimental myocardial infarcted rats. Int J Cardiol 165(3):494–498
Sharmila ST, Rajadurai M (2012) Preventive effect of Bio-Aq on cardiac markers, lipids, and membrane bound enzymes in isoproterenol-induced myocardial infarction in rats. Asian J Pharm Clin Res 5(2):107–113
Upaganlawar A, Gandhi C, Balaraman R (2009) Effect of green tea and vitamin E combination in isoproterenol induced myocardial infarction in rats. Plant Foods Hum Nutr 64:75–80
Wang H, Yang Y, Zhang H, Yan H, Wu X, Zhang C (2014) Administration of the resveratrol analogues isorhapontigenin and heyneanol-a protects mice hematopoietic cells against irradiation injuries. BioMed Research International. Volume 2014: Article ID 282657
Wang QL, Lin M, Liu GT (2001) Antioxidative activity of natural isorhapontigenin. Jpn J Pharmacol 87:61–66
Acknowledgments
We thank Doctor Abdelhadi M. Shebl, Lecturer of Pathology, Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt, for his assistance in histopathological studies.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no competing interests.
Rights and permissions
About this article
Cite this article
Abbas, A.M. Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats. J Physiol Biochem 72, 469–484 (2016). https://doi.org/10.1007/s13105-016-0494-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-016-0494-4